Clinical & translational oncology

• 

  Año 2020, Vol. 22, Número 12 (December)

  • Review Article

    • Research progress of tumor microenvironment and tumor-associated macrophages

      W. Liang, X. Huang, C. J. J. Carlos, X. Lu

      • Resumen

      págs. 2141-2152

      

    • Indicators of a pro-tumor immune response are evident at early stages of breast cancer

      C. Zhang, Robert A. Kurt

      • Resumen

      págs. 2153-2161

      

    • The new function of circRNA: translation

      Y. Shi, X. Jia, J. Xu

      • Resumen

      págs. 2162-2169

      

    • Potential biomarkers for early detection of pancreatic ductal adenocarcinoma

      D. Kriz, D. Ansari, R. Andersson

      • Resumen

      págs. 2170-2174

      

    • Latest progress in molecular biology and treatment in genitourinary tumours

      Aránzazu González del Alba Baamonde, J. A. Arranz Arija, Joaquim Bellmunt, Pablo Maroto Rey, Ovidio Fernández Calvo, B. Pérez Valderrama, Enrique González Billalabeitia, María José Méndez Vidal, Javier Cassinello Espinosa, Nuria Romero Laorden, Miguel Ángel Climent Durán, Javier Puente Vázquez, Ignacio Peláez Fernández, Martin Lázaro Quintela, Enrique Gallardo-Díaz, Cristina Suárez

      • Resumen

      págs. 2175-2195

      

    • Tumor microenvironment, immune response and post-radiotherapy tumor clearance

      Michael Koukourakis, A. Giatromanolaki

      • Resumen

      págs. 2196-2205

      

    • Maintenance treatment in advanced HER2-negative gastric cancer

      Y. Yao, R. Deng, D. Liao, H. Xie, J. Zuo, Y. Jia, F. Kong

      • Resumen

      págs. 2206-2212

      

  • Research Article

    • The free amino acid profiles and metabolic biomarkers of predicting the chemotherapeutic response in advanced sarcoma patients

      B. Jia, W. Wang, S. Lin, L. Shi, Y. Li, Y. Gu, F. Gao, Y. Qin

      • Resumen

      págs. 2213-2221

      

    • A population perspective on the use of external beam radiotherapy in Catalonia, Spain

      J. Corral, J. Solà, Jaume Galceran Padrós, Rafael Marcos Gragera, M. Carulla, A. Izquierdo Font, L. Vilardell, L. Llauradó, Josep Alfons Espinàs, Josep Maria Borràs Andrés

      • Resumen

      págs. 2222-2229

      

    • LncRNA DCST1-AS1 downregulates miR-29b through methylation in glioblastoma (GBM) to promote cancer cell proliferation

      S. Hu, Y. Yao, X. Hu, Y. Zhu

      • Resumen

      págs. 2230-2235

      

    • Salvage radiotherapy in patients affected by oligorecurrent pelvic nodal prostate cancer

      G. Ingrosso, C. Mariucci, M. V. Tenti, V. Bini, E. Alì, S. Saldi, I. Palumbo, R. Bellavita, C. Aristei

      • Resumen

      págs. 2236-2243

      

    • FAM83H overexpression predicts worse prognosis and correlates with less CD8+ T cells infiltration and Ras-PI3K-Akt-mTOR signaling pathway in pancreatic cancer

      Hongkai Zhuang, C. Zhang, Baohua Hou

      • Resumen

      págs. 2244-2252

      

    • Study of the Spanish Society of Medical Oncology (SEOM) on the access to oncology drugs and predictive biomarkers in Spain

      Álvaro Rodríguez Lescure, Francisco Ayala de la Peña, Enrique Aranda Aguilar, Aitana Calvo Ferrándiz, Enriqueta Felip Font, María Pilar Garrido López, Ruth Vera García

      • Resumen

      págs. 2253-2263

      

    • The importance of adjuvant treatment and primary anatomical site in head and neck basaloid squamous cell carcinoma survival: an analysis of the National Cancer Database

      J. Gootee, M. Patel, S. Aurit, P. Silberstein

      • Resumen

      págs. 2264-2274

      

    • Potential roles of lymphovascular space invasion based on tumor characteristics provide important prognostic information in T1 tumors with ER and HER2 positive breast cancer

      Y. Zhao, N. Yang, X. Wang, Y. Huang, X. Zhou, D. Zhang

      • Resumen

      págs. 2275-2285

      

    • Radiotherapy is safe in patients with implantable cardiac devices. Analysis of a systematic interrogation follow-up

      V. López Honrubia, Víctor M. Hidalgo Olivares, M. Dobón Roux, M. M. Martí Laosa, S. Castro Larefors, J. Fernandez Lopez, I. Andrés-García, Olga Roche Losada, Angeles Rovirosa Casino, Meritxell Arenas Prat, F. Martinez Terol, T. López Fernández, Sebastià Sabater

      • Resumen

      págs. 2286-2292

      

    • hsa_circ_0121582 inhibits leukemia growth by dampening Wnt/β-catenin signaling

      J.-J. Chen, P. Lei, M. Zhou

      • Resumen

      págs. 2293-2302

      

    • Clinical activity of brigatinib in ROS1-rearranged non-small cell lung cancer

      E. Dudnik, A. Agbarya, R. Grinberg, A. Cyjon, J. Bar, M. Moskovitz, N. Peled, Israel Lung Cancer Group

      • Resumen

      págs. 2303-2311

      

    • FHOD3 promotes carcinogenesis by regulating RhoA/ROCK1/LIMK1 signaling pathway in medulloblastoma

      J. Yu, W. Shi, R. Zhao, W. Shen, H. Li

      • Resumen

      págs. 2312-2323

      

    • Cytotoxic T lymphocyte antigen-4 (CTLA-4) expression in chordoma and tumor-infiltrating lymphocytes (TILs) predicts prognosis of spinal chordoma

      G. He, X. Liu, X. Pan, Y. Ma, X. Liu

      • Resumen

      págs. 2324-2332

      

    • Dynamic evaluation of neutrophil-to-lymphocyte ratio as prognostic factor in stage III non-small cell lung cancer treated with chemoradiotherapy

      V. Palomar Abril, T. Soria Comes, Sonia Tarazona Campos, María Martín Ureste, Vicent Giner Bosch, Inmaculada Maestu Maiques

      • Resumen

      págs. 2333-2340

      

    • 100% peer review in radiation oncology: is it feasible?

      E. Martin Garcia, Francisco Javier Celada Álvarez, José Pérez Calatayud, M. Rodriguez Pla, O. Prato Carreño, D. Farga Albiol, O. Pons Llanas, S. Roldán, E. Collado, F. J. Martinez Arcelus, Y. Bernisz Diaz, Víctor Macías Hernández, José María Chimeno Hernández, José Gimeno Olmos, F. Lliso Valverde, V. Carmona Meseguer, J. C. Ruiz, Alejandro Tormo Micó, Antonio José Conde Moreno

      • Resumen

      págs. 2341-2349

      

  • Brief Research Article

    • Stereotactic body radiation therapy for liver metastasis from colorectal cancer: size matters

      S. Flamarique, M. Campo Vargas, Gemma Asín Felipe, Santiago Pellejero Pellejero, A. Viudez, Fernando Arias de la Vega

      • Resumen

      págs. 2350-2356

      

    • Prognostic impact of Claudin 18.2 in gastric and esophageal adenocarcinomas

      A. Arnold, S. Daum, Moritz von Winterfeld, E. Berg, M. Hummel, B. Rau, U. Stein, C. Treese

      • Resumen

      págs. 2357-2363

      

    • Covid-19 transmission, outcome and associated risk factors in cancer patients at the first month of the pandemic in a Spanish hospital in Madrid

      J. Rogado, B. Obispo Portero, Cristina Pangua Méndez, Gloria Serrano Montero, Almudena Martín Marino, M. Pérez Pérez, Ana López Alfonso, Pedro Gullón Tosio, Miguel Ángel Lara Álvarez

      • Resumen

      págs. 2364-2368